It was a small-scale study (just 15 participants) whose researchers received their liposomal NMN from a company that sells it (a potential introductory point for bias)
One of the medicines in XIGDUO XR, dapagliflozin (FARXIGA), can also be used in adults with type 2 diabetes who have: chronic kidney disease and dapagliflozin is needed to reduce the risk of further worsening of your kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalization for heart failure
However, Byetta and its extended-release version Bydureon BCise were discontinued in 2024
Their use constitutes off-label administration, and the current clinical evidence for their efficacy in this context is limited
Semaglutide is started at a low dose, and its dosage is increased gradually during the titration phase to minimize the risk of side effects and give your body enough time to adjust